BiPar Sciences

BiPER Therapeutics

This company develops small molecule drugs targeting the BiP protein to treat gastrointestinal cancers and other pathological conditions in humans.

ARase Therapeutics

This company develops small molecule drugs targeting ADP-ribose hydrolases for patients with various forms of cancer.

1200 Pharma

This biotechnology firm develops small molecule therapies and drug intellectual property for the treatment of cancer patients.

TESARO

This biopharmaceutical company develops and commercialises oncology medicines, including treatments for ovarian and endometrial cancers, for patients undergoing chemotherapy or with specific genetic mutations.

Proteolix

This biopharmaceutical company develops proteasome-inhibitor drugs for patients with multiple myeloma and other cancer types.

OnCusp Therapeutics

This biopharmaceutical company develops oncology therapies by advancing preclinical drug candidates through clinical trials for cancer patients and potential pharmaceutical partners.

Ribon Therapeutics

This biotechnology company develops small molecule inhibitors targeting stress support pathways for patients with cancer and inflammatory diseases.

Calithera BioSciences

This biopharmaceutical company develops small-molecule drugs targeting tumor metabolism and immunology to treat patients with various forms of cancer.